News and Insights

Defining and Demonstrating Value

Risk-Sharing Agreements in the EU and Considerations for Moving Forward

Pharmaceutical Technology Europe

Payers across the globe are becoming increasingly assertive regarding products whose costs aren’t in line with perceived performance—a trend that shows no signs of slowing down. In fact, Express Scripts, one on the largest pharmacy benefit managers (PBMs) in the United States, recently announced a plan that would link the…

Preparing for Population Health Management


Although there have been modest successes in “bending the cost curve,” healthcare spending in the U.S. continues to reach unprecedented heights.  Over the next decade, healthcare costs are on track to nearly double, going from $2.9 to $5.2 trillion.1  What’s worse is that while the U.S. spends far more per…

Reference Pricing on the Horizon


The progression toward value-based care has enormous implications for manufacturers, influencing change in everything from pipeline investments to sales strategy.  Two critical trends stemming from the move to value are the increasing role of the consumer, and demands for price and outcome transparency.  Tapping into both of these trends is…

Considerations for Risk Sharing Agreements


In a recent move that garnered considerable attention, Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the US, announced a plan that would link the price of some cancer drugs to their real-world performance.1 Although this isn’t the first time that an alternative pricing model for drugs has…

Capturing the Value from Value-Added Services


What is one of the hottest topics among pharmaceutical and medical device companies looking for a way to grow or even maintain top line revenues? In three words, Value Added Services (VAS). Creating these programs does come with significant challenges, such as demonstrating the value created—whether as a service wrap…

Key Considerations for Successful Data Collaborations


With the recent explosion of healthcare data in the U.S. as well as the announcement of several well-publicized partnerships between manufacturers and providers or payers, the emergence of data collaborations is currently one of the hottest trends in healthcare. It’s no secret that the pharmaceutical industry is facing a series…